Maternal aromatase inhibition via letrozole altered RFamide-related peptide-3 and gonadotropin-releasing hormone expression in pubertal female rats

Despite prevalence of polycystic ovary syndrome (PCOS) among childbearing women and development of many animal models for this syndrome, information on its etiology is still scarce. The intrauterine hyperandrogenic environment may underlie changes at the level of hypothalamus, pituitary, ovary organ...

Full description

Saved in:
Bibliographic Details
Published in:Iranian journal of basic medical sciences 2022-01, Vol.25 (1), p.110-120
Main Authors: Shaaban, Zahra, Tamadon, Amin, Jafarzadeh Shirazi, Mohammad Reza, Zamiri, Mohammad Javad, Derakhshanfar, Amin
Format: Article
Language:English
Subjects:
gonadotropin-releasing hormone
hypothalamus
letrozole
Original
Ovaries
Physical growth
Polycystic ovary syndrome
polycystic ovary syndrome prenatal
rat
rfamide-related peptide-3
Rodents
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Despite prevalence of polycystic ovary syndrome (PCOS) among childbearing women and development of many animal models for this syndrome, information on its etiology is still scarce. The intrauterine hyperandrogenic environment may underlie changes at the level of hypothalamus, pituitary, ovary organization in female offspring, and PCOS later in life. Letrozole has been shown to mimic reproductive and metabolic characteristics of PCOS in adult rodent models. Therefore, this research aimed to assess the condition in a prenatal letrozole-treated rat model. Twenty-eight female rats dams receiving letrozole at certain doses during late pregnancy were used in the trial. Pregnant Sprague-Dawley rats (n=21) received letrozole treatment on gestation days 16-18 at doses of 1.25, 1.0, 0.75, 0.5, and 0.25 mg/kg body weight (BW). Prenatal letrozole treatment delayed parturition time and reduced the litter size in pregnant dams (
ISSN:2008-3866
2008-3874
DOI:10.22038/IJBMS.2022.60962.13499